University of Notre Dame
Browse
8,846,059 OCR.pdf (990.21 kB)

Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer

Download (990.21 kB)
standard
posted on 2017-07-31, 00:00 authored by Mark A. Suckow, William R. Wolter
Compositions suitable for use as ovarian cancer and/or tumor adjuvants in the preparation of ovarian cancer vaccines, particularly those vaccines useful in the treatment of human ovarian cancer, are provided. The ovarian cancer adjuvants described are comprised of an extracellular matrix material, such as small intestinal submucosal (SIS) tissue. The preparations may take the form of sheets, gels, liquids (injectable), tracer, or other solid or semi-solid preparation. Also disclosed are ovarian tumor inhibiting compositions that include extracellular matrix tissue adjuvants.

History

Patent Number

US 8846059 B2

Other Application

12/633,152

Inventor

Mark A. Suckow William R. Wolter

Inventor from Local Institution

Mark A. Suckow William R. Wolter

Assignee

University of Notre Dame du Lac

Date Modified

2017-07-31

Language

  • English

Claims

14

Prior Publication Number

US 20110135690 A1

Publisher

U.S. Patent and Trademark Office

Cooperative Patent Classification Codes

A61K 39/0011 (20130101); A61K 2039/55588 (20130101)

Contributor

Mark A. Suckow|William R. Wolter

International Patent Classification Codes

A61K 9/00 (20060101); A61K 9/70 (20060101); A61K 9/14 (20060101)

US Patent Classification Codes

424/277.1; 424/423; 424/443; 424/484; 424/489

Usage metrics

    Patents

    Categories

    No categories selected

    Keywords

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC